CONTACT US
contact us
logotype
CONTACT US

Have a Project in Mind? Say Hi!

  • Mon - Sun: 10am - 10pm
  • 27 Division St, New York,
    NY 10002, USA​
Home2025January
January 2025
January 7, 2025
PR NeweswireBY admin

Qnovia, Inc. Announces First Patient Dosed in U.S. in Phase 1 study for RespiRx™ Nicotine Inhaler as a prescription smoking cessation therapy

READ MORE
#side-panel.side-panel {width: 500px;}#side-panel.side-panel .side-panel_sidebar {padding: 70px 0px 50px 60px;background-color: #FFFFFF;} Qnovia